Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression
by on Friday, August 31st, 2012 | No Comments
Conditions: Malignant Solid Tumour; Triple-negative Breast Cancer
Intervention: Drug: Dinaciclib & paclitaxel treatment
Sponsors: University of California, San Francisco; Jo Chien; Merck
Recruiting – verified August 2012
View original post here: Phase I/Ib Dose-escalation of Dinaciclib With Weekly Paclitaxel for Advanced Solid Tumor Malignancies & Assessment of MYC Oncogene Overexpression